Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Evaluation of Arts-Based Storytelling Program in Adolescents With Diabetes

7 août 2026 mis à jour par: University of California, San Francisco

The goal of this clinical trial is to evaluate whether an arts-based storytelling and narrative medicine workshop series can improve social connection, illness identity, and psychological well-being in adolescents and young adults with chronic illness, specifically diabetes.

The main questions it aims to answer are:

  • Does participation in a narrative-based storytelling workshop improve social connectedness and peer support among adolescents and young adults with diabetes?
  • Does engagement in creative arts and reflective storytelling support identity formation, self-expression, and emotional well-being in this population?

Participants will be 16-25 years old and recruited through the UCSF Pediatric Diabetes Clinic. Individuals must be able to participate in group workshops and complete surveys and interviews related to the study.

Participants will:

  • Attend eight weekly workshops centered on storytelling, reflection, and creative expression
  • Engage in narrative medicine activities, including writing, storytelling, drawing, and facilitated reflection
  • Participate in group discussions focused on personal experiences with chronic illness
  • Complete pre- and post-intervention surveys assessing psychosocial outcomes such as social connectedness, illness identity, self-concept, and mental well-being
  • Participate in interviews and reflective exercises about their experiences in the program

This study aims to explore the role of narrative medicine and arts-based interventions in supporting adolescents and young adults with chronic illness and assess their potential benefits as a supplement to standard medical care.

Aperçu de l'étude

Statut

Actif, ne recrute pas

Les conditions

Intervention / Traitement

Type d'étude

Interventionnel

Inscription (Estimé)

10

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

  • États-Unis
    • California
      • San Francisco, California, États-Unis, 94107
        • University of California, San Francisco

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Enfant
  • Adulte

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Participants must be patients at the UCSF Pediatric Diabetes Clinic
  • Participants must have a self-reported diagnosis of diabetes
  • Participants must be between 16-25 years old
  • The participant and/or caregiver(s) must be English-speaking

Exclusion Criteria:

  • Participants unable to attend the first session

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: N / A
  • Modèle interventionnel: Affectation à un seul groupe
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Arts-Based Storytelling Workshop Series
Participants in this study will take part in an eight-week arts-based storytelling workshop series designed to promote social connection, self-expression, illness identity development, and psychological well-being in adolescents and young adults with diabetes. Workshops will be conducted weekly and will include: -Close engagement with written, visual, or artistic materials centered on themes such as identity, resilience, relationships, uncertainty, growth, and coping with chronic disease - Facilitated group discussions and sharing intended to foster peer support, connection, emotional processing, and self-expression - Creative arts exercises, including writing, storytelling, drawing, or other forms of creative expression in response to structured prompts
Comportemental: Arts-Based Storytelling Workshop Series
The Arts-Based Storytelling Workshop Series is a structured eight-week behavioral intervention designed to enhance self-expression, social connection, emotional reflection, and psychological well-being in adolescents and young adults with diabetes. This intervention differs from traditional educational or counseling approaches by integrating creative expression, guided reflection, and group dialogue as therapeutic tools. Each weekly session includes: -Engagement with written, visual, or artistic prompts centered on themes such as identity, resilience, relationships, coping, uncertainty, and growth in the context of chronic illness -Facilitated group discussion and sharing designed to promote peer support, emotional processing, and a sense of community among participants - Creative exercises in response to structured prompts, including writing, storytelling, drawing, or other expressive activities that support personal reflection

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Participant retention and attendance
Délai: Throughout intervention (Weeks 1-8), assessed immediately post-intervention (Week 8)
Feasibility will be assessed by tracking the number of participants who attend each of the 8 weekly sessions, including overall completion of the program.
Throughout intervention (Weeks 1-8), assessed immediately post-intervention (Week 8)
Participant satisfaction
Délai: Immediately post-intervention (Week 8)
Acceptability will be assessed using post-intervention satisfaction questionnaires with 5-point Likert-scale items and semi-structured individual interviews. Measures will evaluate perceived relevance of workshop content, usefulness of creative prompts, quality of group discussion, and facilitation experience. Scale title: Intervention Satisfaction Questionnaire (ISQ) Minimum value: 1 (Strongly Disagree) Maximum value: 5 (Strongly Agree) Interpretation: Higher scores indicate greater satisfaction with the intervention.
Immediately post-intervention (Week 8)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Illness identity
Délai: Pre-intervention (Week 0) and post-intervention (Week 8)
Assessed using the Illness Identity Questionnaire, which evaluates how individuals integrate a chronic illness into their sense of self. Scores reflect different illness identity orientations, with higher scores indicating stronger endorsement of the corresponding identity state. Scale title: Illness Identity Questionnaire (IIQ) Minimum value: 1 (Strongly Disagree) Maximum value: 5 (Strongly Agree) Interpretation: Subscale scores reflect distinct illness identity states; higher scores indicate greater endorsement of that identity orientation
Pre-intervention (Week 0) and post-intervention (Week 8)
Social connectedness
Délai: Pre-intervention (Week 0) and post-intervention (Week 8)
Measured using the Social Connectedness Scale (SCS), which assesses perceived closeness to others and sense of belonging. Scale title: Social Connectedness Scale (SCS) Minimum value: 1 (Strongly Disagree) Maximum value: 6 (Strongly Agree) Interpretation: Higher scores indicate greater feelings of social connectedness and belonging.
Pre-intervention (Week 0) and post-intervention (Week 8)
Self-reported well-being
Délai: Pre-intervention (Week 0) and post-intervention (Week 8)
Measured using the WHO-5 is a self-report instrument measuring mental well-being. Scale title: Psychosocial functioning scale (PFQ) Minimum value: 0 (At no time) Maximum value: 5 (All of the time) Interpretation: Higher scores indicate greater well-being.
Pre-intervention (Week 0) and post-intervention (Week 8)
Self-esteem
Délai: Pre-intervention (Week 0) and post-intervention (Week 8)
Measured using the Rosenberg Self-Esteem Scale (RSE), which assesses global self-worth, self-worth and self-acceptance. Scale Minimum value: 1 (Strongly agree) Maximum value: 4 (Strongly disagree) Interpretation: Higher total scores indicating more positive self-esteem.
Pre-intervention (Week 0) and post-intervention (Week 8)
Qualitative themes from interviews and group reflections
Délai: Pre-intervention (Week 0) and post-intervention (Week 8)
Semi-structured interviews will explore participant experiences of identity development, meaning-making, peer support, and emotional processing. Transcripts will be analyzed using thematic analysis to identify recurring patterns and narrative themes related to chronic illness experience and psychosocial adaptation.
Pre-intervention (Week 0) and post-intervention (Week 8)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

University of California, San Francisco

Les enquêteurs

  • Chercheur principal: Anoushka Sinha, MD, MS, University of California, San Francisco
  • Chaise d'étude: Lina Lew, BS, University of California, San Francisco
  • Chaise d'étude: Calis Lim, BS, Rosalind Franklin University

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

13 juillet 2026

Achèvement primaire (Estimé)

1 septembre 2026

Achèvement de l'étude (Estimé)

1 septembre 2026

Dates d'inscription aux études

Première soumission

29 mai 2026

Première soumission répondant aux critères de contrôle qualité

29 mai 2026

Première publication (Réel)

4 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

11 août 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

7 août 2026

Dernière vérification

1 août 2026

Plus d'information

Termes liés à cette étude

Termes MeSH pertinents supplémentaires

Autres numéros d'identification d'étude

  • 26-46489

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner